[1] 何智慧.脂联素调节代谢的作用机制研究[J].生物化工,2021,7(4):142~143,161. [2] 翟鑫,等.老年2型糖尿病合并冠心病患者胰岛素抵抗与脂代谢及脂联素的相关性分析[J].重庆医学,2021,50(15):2539~2543. [3] Arita Y,et al.Paradoxical decrease of an adipose-specific protein,adiponectin,in obesity[J].Biochem Biophys Res Commun,2012,425(3):560~564. [7] Singh P,et al.Differential effects of leptin on adiponectin expression with weight gain versus obesity[J].Int Obes (Lond),2016,40(2):266~274. [4] Cisneros-Zevallos L,W Y,Bang and C.Delgadillo-puga,ellagic acid and urolithins A and B differentially regulate fat accumulation and inflammation in 3T3-L1 adipocytes while not affecting adipogenesis and insulin sensitivity[J].Int Mol Sci,2020,21(6). [5] Tanabe H,et al.Crystal structures of the human adiponectin receptors[J].Nature,2015,520(7547):312~316. [6] Holland W.L,et al.Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin[J].Nat Med,2011,17(1):55~63. [7] Deepa S S,et al.APPL1 mediates adiponectin-induced LKB1 cytosolic localization through the PP2A-PKCzeta signaling pathway[J].Mol Endocrinol,2011,25(10):1773~1185. [8] Ryu J,et al.APPL1 potentiates insulin sensitivity by facilitating the binding of IRS1/2 to the insulin receptor[J].Cell Rep,2014,7(4):1227~1238. [9] Ruan H,L Q Dong.Adiponectin signaling and function in insulin target tissues[J].Mol Cell Biol,2016,8(2):101~109. [10] Chaurasia B,S A Summers.Ceramides - lipotoxic inducers of metabolic disorders[J].Trends Endocrinol Metab,2015,26(10):538~550. [11] Wang Z V,P E Scherer.Adiponectin,the past two decades[J].Mol Cell Biol,2016,8(2):93~100. [12] Vasiliauskaite-Brooks I,et al.Structural insights into adiponectin receptors suggest ceramidase activity[J].Nature,2017,544(7648):120~123. [13] Matsuda K,et al.Positive feedback regulation between adiponectin and T-cadherin impacts adiponectin levels in tissue and plasma of male mice[J].Endocrinology,2015,156(3):934~946. [14] 谭跃,等.老年人高体质指数与血脂参数和脂联素水平相关性分析[J].中国老年保健医学,2021,19(3):40~43. |